← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Discovery Genomics, Inc.
Minneapolis, MN
$6,081,882
Total funding
11
Grants
Funding over time
peak $857.4K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$6,081,882 · 11
By mechanism
R44$4,142,690 · 2
R43$1,236,385 · 6
R41$702,807 · 3
Investigators at Discovery Genomics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Sleeping Beauty-Mediated Gene Therapy for Hemophilia$716,704
R44 · FY2011 · HL
Sleeping Beauty-Mediated Gene Therapy for Hemophilia$649,762
R44 · FY2006 · HL
Sleeping Beauty-Mediated Gene Therapy for Hemophilia$595,423
R44 · FY2005 · HL
Sleeping Beauty-Mediated Gene Therapy for Hemophilia$570,317
R44 · FY2012 · HL
Transposon-Mediated Gene Therapy for Fanconi Anemia$566,484
R44 · FY2008 · HL
Transposon-Mediated Gene Therapy for Fanconi Anemia$564,735
R44 · FY2007 · HL
Sleeping Beauty-Mediated Gene Therapy for Hemophilia$479,265
R44 · FY2013 · HL
Delivery of Sleeping Beauty Transposons to Dog Liver for Gene Therapy$290,918
R41 · FY2008 · DK
Sleeping Beauty-mediated Gene Therapy of X-linked SCID$270,673
R43 · FY2010 · AI
Transposon-mediated Gene Therapy for Fanconi Anemia$235,588
R43 · FY2004 · HL
Sleeping Beauty Engineered B Cells for Mucopolysaccharidosis$224,484
R43 · FY2015 · GM
Sleeping Beauty Mediated Therapy for Alpha V Beta 6-Expressing Pancreatic Cancer$200,244
R43 · FY2013 · CA
Targeted Transposons for Gene Therapy$174,011
R41 · FY2007 · EB
Brain Tumor Stem Cell-targeted Gene Therapy$163,582
R41 · FY2006 · CA
ANGIOGENESIS TARGETS FOR THERAPEUTIC DEVELOPMENT$160,301
R43 · FY2004 · CA
Sleeping Beauty-Mediated Gene Therapy for Hemophilia A$145,095
R43 · FY2003 · HL
Brain Tumor Stem Cell-targeted Gene Therapy$74,296
R41 · FY2007 · CA